healthy normals, phase 1
Showing 1 - 25 of >10,000
Healthy Trial in Christchurch (LTG-001, Placebo)
Not yet recruiting
- Healthy
- LTG-001
- Placebo
-
Christchurch, New ZealandClinical Research Unit
Sep 21, 2023
Healthy Volunteers Trial in Melbourne (Verasone)
Not yet recruiting
- Healthy Volunteers
-
Melbourne, Victoria, AustraliaNucleus Network
Nov 19, 2023
Healthy Trial in Madison (Fadraciclib)
Active, not recruiting
- Healthy
-
Madison, WisconsinLabcorp Clinical Research Unit
Apr 5, 2023
Healthy Trial (Daridorexant 10 mg, Daridorexant 25 mg)
Not yet recruiting
- Healthy
- Daridorexant 10 mg
- Daridorexant 25 mg
- (no location specified)
Jun 1, 2023
Ischemia-reperfusion Injury Trial in Adelaide (BX-001N Part 1, BX-001N Part 2, Placebo)
Not yet recruiting
- Ischemia-reperfusion Injury
- BX-001N Part 1
- +2 more
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Oct 19, 2023
Healthy Subjects Trial in SEoul (C1K, Placebo)
Recruiting
- Healthy Subjects
- C1K
- Placebo
-
SEoul, Korea, Republic ofSeoul National University Clinical Trial Center
Aug 3, 2023
Healthy Adult Subjects Trial in Seoul (ID110521156, Placebo of ID110521156)
Not yet recruiting
- Healthy Adult Subjects
- ID110521156
- Placebo of ID110521156
-
Seoul, Korea, Republic ofSeoul National University Hospital
Sep 26, 2023
Nonalcoholic Steatohepatitis Trial in Taipei (HUYPS-1 one tablet, HUYPS-1 nine tablets)
Completed
- Nonalcoholic Steatohepatitis
- HUYPS-1 one tablet
- HUYPS-1 nine tablets
-
Taipei, TaiwanTri-Service General Hospital
Aug 1, 2023
Healthy Subjects Trial in Melbourne (AP301)
Not yet recruiting
- Healthy Subjects
-
Melbourne, Victoria, AustraliaNucleus Network Pty Ltd
Oct 20, 2023
Healthy Male Subjects Trial in Lincoln (14C RPT193)
Not yet recruiting
- Healthy Male Subjects
- 14C RPT193
-
Lincoln, NebraskaCelerion
Oct 13, 2023
Chikungunya Virus Infection Trial (VLA1553 full dose, VLA1553 half dose, Control)
Not yet recruiting
- Chikungunya Virus Infection
- VLA1553 full dose
- +2 more
- (no location specified)
Oct 24, 2023
Healthy Trial (DA-8010 5mg, Clarithromycin 500mg, Rifampicin 600mg)
Not yet recruiting
- Healthy
- DA-8010 5mg
- +2 more
- (no location specified)
Aug 11, 2023
Safety and Tolerability Trial in Shanghai (JMKX003002 will be administered orally, Placebo in Cohorts 1 to 5, Placebo in 2
Recruiting
- Safety and Tolerability
- JMKX003002 will be administered orally
- +2 more
-
Shanghai, Shanghai, ChinaHuashan Hospital Fudan University
Jun 15, 2023
Healthy Trial in Québec (Camlipixant + Gemfibrozil, Dabigatran etexilate + camlipixant)
Not yet recruiting
- Healthy
- Camlipixant + Gemfibrozil
- Dabigatran etexilate + camlipixant
-
Québec, Quebec, CanadaSyneos Health
Jul 17, 2023
Healthy Adult Subjects Trial in San Antonio (TTYP01, Radicava, Radicava ORS)
Recruiting
- Healthy Adult Subjects
- TTYP01
- +2 more
-
San Antonio, TexasICON Early Phase Services
Oct 24, 2023
Adrenocortical Carcinoma Trial in Ann Arbor (68Ga-R8760 injection at pre-defined dose levels, 68GA-R8760 injection)
Recruiting
- Adrenocortical Carcinoma
- 68Ga-R8760 injection at pre-defined dose levels
- 68GA-R8760 injection
-
Ann Arbor, MichiganUniversity of Michigan Nuclear Medicine
Aug 11, 2023
Cocaine Use Disorder, Substance Use Disorders, Healthy Volunteers Trial in Overland Park (TMP-301, Placebo)
Active, not recruiting
- Cocaine Use Disorder
- +2 more
- TMP-301
- Placebo
-
Overland Park, KansasAltasciences
Aug 29, 2023
Parkinson Disease Psychosis, Amyotrophic Lateral Sclerosis (ALS) Trial (FB418)
Not yet recruiting
- Parkinson Disease Psychosis
- Amyotrophic Lateral Sclerosis (ALS)
- (no location specified)
Aug 13, 2023
Healthy Trial in Adelaide (XH-S003 (A), Placebo (B))
Not yet recruiting
- Healthy
- XH-S003 (A)
- Placebo (B)
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Jul 21, 2023